Epigenetic reader domain inhibitor dBET1, Purity ≥98%

Cat. No.: X24-05-ZQ441

Epigenetic reader domain inhibitor dBET1, Purity ≥98%

Synonym: 1799711-21-9; dBET-1; dBET 1; Epigenetic reader domain inhibitor

  • CAS Number: 1799711-21-9
  • Compound CID: 91799313
Product Size
2 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
dBET1, soluble in DMSO, water and ethanol, disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals. It targets BRD4 and Cereblon.
Molecular Weight
785.27
Molecular Formula
C38H37ClN8O7S
Targets
BRD4: 430 nM (EC50); Cereblon
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 89 mg/mL (113.33 mM); Water: <1 mg/mL; Ethanol: 35 mg/mL (44.57 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
dBET1 can be used in research to degrade BRD4 and study the resulting cellular responses and therapeutic potential.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.